Search results for "Fever of unknown origin"

showing 10 items of 15 documents

Fever of unknown origin in a mediterranean survey from a division of internal medicine: report of 91 cases during a twelve-year-period (1991-2002)

2008

internal medicineFever of unknown originSettore MED/09 - Medicina InternaFever of unknown origin; mediterranean survey; internal medicine;mediterranean survey
researchProduct

Early detection of pneumonia in febrile neutropenic patients: use of thin-section CT.

1997

The purpose of this study was to evaluate the usefulness of thin-section CT for early detection of pneumonia in neutropenic patients with an unknown site of infection and normal or nonspecific findings on chest radiographs.Eighty-seven patients with febrile neutropenia that persisted for more than 2 days despite empiric antibiotic treatment underwent 146 prospective examinations. If findings on chest radiographs were normal (n = 126) or nonspecific (n = 20), thin-section CT (1-mm collimation, 10-mm increment) was done. If thin-section CT scans showed opacities, bronchoalveolar lavage was recommended.Findings on chest radiographs were nonspecific for pneumonia in 20 (14%) of 146 cases, and C…

Malemedicine.medical_specialtyNeutropeniaTime FactorsRadiographyAntineoplastic AgentsNeutropeniaFever of Unknown OriginPredictive Value of TestsRisk FactorsNeoplasmsmedicineHumansRadiology Nuclear Medicine and imagingProspective StudiesMycosisLeukopeniamedicine.diagnostic_testbusiness.industryRespiratory diseasePneumoniaGeneral MedicineMiddle Agedmedicine.diseaserespiratory tract diseasesSurgeryPneumoniaBronchoalveolar lavageEvaluation Studies as TopicFemaleRadiologymedicine.symptomTomography X-Ray ComputedbusinessBronchoalveolar Lavage FluidFebrile neutropeniaAmerican Journal of Roentgenology
researchProduct

Management of febrile neutropenia in the perspective of antimicrobial de-escalation and discontinuation.

2019

Introduction: Infections are among the most frequent complications in patients with hematological and oncological diseases. They might be classified as fever of unknown origin and microbiologically or clinically documented infections. Optimal duration of antimicrobial treatment is still unclear in these patients.Areas covered: We provide an overview on the management of febrile neutropenia in the perspective of antimicrobial de-escalation and discontinuation.Expert opinion: Patients with febrile high-risk neutropenia should be treated empirically with an anti-pseudomonal agent such as piperacillin/tazobactam. Several clinical studies support the assumption that the primary antibiotic regime…

0301 basic medicineMicrobiology (medical)medicine.medical_specialtyAntifungal Agents030106 microbiologyNeutropeniaMicrobiologyTazobactam03 medical and health sciencesAntimicrobial Stewardship0302 clinical medicineAnti-Infective AgentsVirologyMedicineHumans030212 general & internal medicineFever of unknown originIntensive care medicineFebrile Neutropeniabusiness.industryDrug Resistance Microbialmedicine.diseaseAntimicrobialDrug Resistance MultipleDiscontinuationAnti-Bacterial AgentsInfectious DiseasesDrug Therapy CombinationbusinessFebrile neutropeniaDe-escalationmedicine.drugPiperacillinExpert review of anti-infective therapy
researchProduct

Fever of Unknown Origin in Internal Medicine: A Reasonable Analysis of Causes and Mistakes

2013

Settore MED/09 - Medicina InternaInternal MedicineFever of Unknown Origin; Internal MedicineFever of Unknown Origin
researchProduct

Low-grade fever: how to distinguish organic from non-organic forms.

2010

Summary Background and aim:  Low-grade fever (LGF) is defined as a body temperature between 37.5 and 38.3 °C, which is below the classical value reported for fever of unknown origin (FUO). We attempted to characterise its epidemiology, aetiology and clinical aspects to improve the methodological approach to diagnosis. Design and Methods:  We reviewed and evaluated a survey of patients with LGF, followed as outpatients of our Department, a tertiary referral centre from 1997 to 2008. The same classifications were applied for classical FUO, and in the patients diagnosed with LGF, we also investigated for habitual hyperthermia (HH). Results:  Seventy-three patients were selected and divided int…

Low-grade feverAdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaFeverorganicPhysical examinationGastroenterologyGroup BLow-grade feverBody TemperatureDiagnosis DifferentialYoung AdultRecurrenceInternal medicineEpidemiologymedicineHumansFever of unknown originYoung adultLow-grade fever; organic; functionalPathologicalPhysical Examinationmedicine.diagnostic_testbusiness.industryGeneral Medicinemedicine.diseaseSurgeryfunctionalEtiologyFemalebusinessInternational journal of clinical practice
researchProduct

Presepsin and Midregional Proadrenomedullin in Pediatric Oncologic Patients with Febrile Neutropenia

2020

Abstract Objective In this study, we investigated the roles of presepsin (PSP) and midregional proadrenomedullin (mr-proADM) in children with febrile neutropenia (FN) due to chemotherapy. Methods We assessed 36 FN episodes in 26 children. Patients were classified into bacteremia (B) and fever of unknown origin (FUO) groups. We evaluated PSP and mr-proADM at admission (T0), after 24/48 h (T1), and after 5 days (T2). Results PSP and mr-proADM levels were elevated at T0 and significantly decreased at T2. mr-proADM levels did not significantly differ between the B and FUO groups. PSP levels significantly differed between the B and FUO groups only at T1. Both PSP and mr-proADM levels at T0 were …

Malemedicine.medical_specialtymedicine.medical_treatmentpediatric.Clinical BiochemistryLipopolysaccharide ReceptorsNeutropeniaAdrenomedullinmr-proADMmalignancieNeoplasmsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsHumansneutropeniaMedicineBlood cultureProtein PrecursorsFever of unknown originChildFebrile NeutropeniafeverChemotherapymedicine.diagnostic_testReceiver operating characteristicbusiness.industryPresepsinBiochemistry (medical)Age FactorsPrognosismedicine.diseasePeptide FragmentsAdrenomedullinROC CurveoncologicBacteremiaFemalebusinessBiomarkersFebrile neutropeniaLaboratory Medicine
researchProduct

Magnetresonanztomographie (MRT) der Leber und des Gehirns bei hämatologisch-onkologischen Patienten mit Fieber unbekannter Ursache

1998

PURPOSE To examine the advantage of liver and brain MRI in clinically anomalous haematological patients with fever of unknown origin. MATERIAL AND METHODS Twenty liver MRI (T2-TSE, T2-HASTE, T1-FLASH +/- Gd dynamic) and 16 brain MRI (T2-TSE, FLAIR, T1-TSE +/- Gd) were performed searching for a focus of fever with a suspected organ system. Comparison with clinical follow-up. RESULTS A focus was detected in 11/20 liver MRI. Candidiasis (n = 3), mycobacteriosis (n = 2), relapse of haematological disease (n = 3), graft versus host disease (n = 1), non-clarified (n02). The remaining 9 cases with normal MRI were not suspicious of infectious hepatic disease during follow-up. In brain MRI, 3/16 sho…

MastoiditisPathologymedicine.medical_specialtybusiness.industryFluid-attenuated inversion recoverymedicine.diseaseAspergillosisToxoplasmosisCentral nervous system diseaseGraft-versus-host diseasemedicineRadiology Nuclear Medicine and imagingFever of unknown originbusinessMycosisRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

Castleman's disease presenting as fever of unknown origin: diagnostic value of fluorodeoxyglucose-positron emission tomography/computed tomography.

2009

Abstract: Castleman's disease is an uncommon lymphoproliferative disorder that can present in both nodal and extranodal sites. The cause is unknown, but a disordered immunoregulation, which results in the excessive proliferation of B lymphocytes and plasma cells in lymphoid organs, plays a central role in the development of the condition. Three distinct histologic types (hyaline vascular, plasma cell, and mixed), and 2 anatomical variants (localized and multicentric) have been described. Clinical presentation generally consists of enlargement of lymph nodes or other tissues, fever, asthenia, weight loss, and other general symptoms, associated with nonspecific blood analysis abnormalities, s…

Pathologymedicine.medical_specialtyFeverDiseasePlasma cellFluorodeoxyglucose F18medicineHumansFever of unknown originHyalinemedicine.diagnostic_testbusiness.industryCastleman diseaseCastleman DiseaseGeneral MedicineMiddle Agedmedicine.diseasemedicine.anatomical_structureLymphatic systemPositron emission tomographyPositron-Emission TomographyFemaleLymphRadiopharmaceuticalsbusinessTomography X-Ray ComputedThe American journal of the medical sciences
researchProduct

Pefloxacin in the Antibacterial Treatment of Immunodepressed Patients

1990

Pefloxacin 800 to 1200 mg daily was given for 3 to 20 days, orally or intravenously, to 84 immunocompromised patients. Five patients dropped out because of side effects and 2 for other causes. Treatment efficacy was evaluated in 77 patients, 43 men and 34 women, aged 18 to 80 years. Immunodepression resulted from malignancy in 46 patients, LAS/ARC or AIDS in 28, and from unknown causes in 3. Fifty-eight patients had documented infections (respiratory-tract infections 29, urinary-tract infections 13, septicemia 10, other 6) and 19 had a fever of unknown origin (FUO). Cure or significant improvement of symptoms was achieved in 81% of patients with documented infections and in 74% of patients …

Adult0301 basic medicinemedicine.medical_specialty030106 microbiologyAIDS-related complexMalignancyPefloxacin03 medical and health sciencesGastrointestinal disturbances0302 clinical medicineAcquired immunodeficiency syndrome (AIDS)NeoplasmsInternal medicineImmune ToleranceHumansMulticenter Studies as TopicMedicinePharmacology (medical)Fever of unknown originAgedAged 80 and overPharmacologyAcquired Immunodeficiency Syndromebusiness.industryBacterial InfectionsMiddle Agedmedicine.diseaseRashPefloxacinTreatment efficacyInfectious DiseasesOncology030220 oncology & carcinogenesismedicine.symptombusinessmedicine.drugJournal of Chemotherapy
researchProduct

Infección por Coxiella burnetii (fiebre Q)

2010

In spite of being described over 60 years, Q fever is still a little known disease. The exact prevalence is also unknown, but probably the number of cases of Q fever is underestimated. There is much variation in the clinical presentation, including severe forms with a poor prognosis. Acute cases often present as an asymptomatic infection, flu-like syndrome, pneumonia or hepatitis. Presumably, host factors play an important role in the development of chronic disease, which may present as endocarditis with negative blood culture. The diagnosis of Q fever should be considered in cases of fever of unknown origin, especially if the subject has been in contact with mammals suspicious to be infect…

Microbiology (medical)Hepatitisbiologybusiness.industryQ feverCoxiella burnetiibiology.organism_classificationmedicine.diseaseAsymptomaticImmunologymedicineEndocarditismedicine.symptomSeroconversionFever of unknown originbusinessPneumonia (non-human)Enfermedades Infecciosas y Microbiología Clínica
researchProduct